期刊名称：BRAIN BEHAVIOR AND IMMUNITY
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
|
Brain, Behavior, and Immunity, founded in 1987, is the official journal of the Psychoneuroimmunology Research Society (PNIRS). This innovative journal publishes peer-reviewed basic, experimental, and clinical studies dealing with behavioral, neural, endocrine, and immune system interactions in humans and animals. It is an international, interdisciplinary journal devoted to investigation of the physiological systems that integrate behavioral and immunological responses. The journal welcomes original research in neuroscience, immunology, integrative physiology, behavioral biology, psychiatry, psychology, and clinical medicine and is inclusive of research at the molecular, cellular, social, and organismic levels. The journal features online submission and review, leading to timely publication of experimental results. There are no submission fees or page charges for Brain, Behavior, and Immunity, which is published six times a year. Detailed instructions for authors can be found at http://www.elsevier.com/locate/ybrbi.
Research areas include:
- Neurochemical and hormonal mechanisms that convey messages to and from the immune system and brain
- Stress and immunity, including the role of stress-related hormones and neurotransmitters on the immune system and brain
- Actions of cytokines and growth factors on neuronal and glial cells to regulate behavior, cognition, and neuroendocrine function
- Roles of hormones, growth factors, and cytokines in the immune and central nervous systems
- Inflammation, neuroscience, and behavior
- Neuroimmunopharmacology and the immunomodulating effects of psychotropic drugs and drugs of abuse
- Sleep, exercise, immunity, and health
- Roles of cytokines, hormones, and neurotransmitters in the aging immune system and brain
- Cancer, brain, and immunity
- Regulation of nerve injury and repair by the immune system
- Psychosocial, behavioral, and neuroendocrine influences on immunity and on the development and progression of immunologically mediated disease processes
Genomics of behavior and immunity
|
|
Instructions to Authors
Brain, Behavior, and Immunity, founded in 1987, is the official journal of the Psychoneuroimmunology Research Society (PNIRS). This innovative journal publishes peer-reviewed basic, experimental, and clinical studies dealing with behavioral, neural, endocrine, and immune system interactions in humans and animals. It is an international, interdisciplinary journal devoted to investigation of the physiological systems that integrate behavioral and immunological responses. The journal welcomes original research in neuroscience, immunology, integrative physiology, behavioral biology, psychiatry, psychology, and clinical medicine and is inclusive of research at the molecular, cellular, social, and organismic levels. The journal features online submission and review, leading to timely publication of experimental results. There are no submission fees or page charges for Brain, Behavior, and Immunity, which is published six times a year. Detailed instructions for authors can be found at http://www.elsevier.com/locate/ybrbi.
Research areas include:
- Neurochemical and hormonal mechanisms that convey messages to and from the immune system and brain
- Stress and immunity, including the role of stress-related hormones and neurotransmitters on the immune system and brain
- Actions of cytokines and growth factors on neuronal and glial cells to regulate behavior, cognition, and neuroendocrine function
- Roles of hormones, growth factors, and cytokines in the immune and central nervous systems
- Inflammation, neuroscience, and behavior
- Neuroimmunopharmacology and the immunomodulating effects of psychotropic drugs and drugs of abuse
- Sleep, exercise, immunity, and health
- Roles of cytokines, hormones, and neurotransmitters in the aging immune system and brain
- Cancer, brain, and immunity
- Regulation of nerve injury and repair by the immune system
- Psychosocial, behavioral, and neuroendocrine influences on immunity and on the development and progression of immunologically mediated disease processes
- Genomics of behavior and immunity
Submission of Manuscripts
An introductory letter outlining the most important findings and their significance should accompany each paper. Manuscripts must be written in English and should be submitted electronically to the Editor-in-Chief at http://www.spltrak.com/bbi. The editorial office of Brain, Behavior, and Immunity is:
Dr. Keith W. Kelley
Editor-in-Chief, Brain, Behavior, and Immunity
University of Illinois at Urbana-Champaign
Laboratory of Immunophysiology
Department of Animal Sciences
212 Edward R. Madigan Laboratory
1201 West Gregory Drive
Urbana, IL 61801, USA
bbieditor@uiuc.edu
Telephone: (217) 333-9641
Fax: (217) 244-5617
http://www.spltrak.com/bbi/
The authors may provide names and addresses of up to five qualified, expert reviewers, but this is not required for manuscript submission. Manuscripts are accepted for review with the understanding that the same work has not been and will not be published elsewhere (except in abstract form) and that it is not being submitted for review elsewhere. It is also understood that all persons listed as authors have given their approval for the submission of the paper and that any person cited as a source of personal communications has approved such citation. Written authorization may be required at the Editor's discretion. Articles and any other material published in Brain, Behavior, and Immunity represent the opinions of the author(s) and should not be construed to reflect the opinions of the Editor(s) or the Publisher.
Authors submitting a manuscript do so on the understanding that if it is accepted for publication, copyright in the article, including the right to reproduce the article in all forms and media, shall be assigned exclusively to the Publisher. Authors are responsible for obtaining permissions to reprint previously published figures, tables, and other material. Letters of permission should accompany the final submission.
Types of Articles
Original full-length research reports, full-length review articles, and brief commentaries will be considered for publication. The journal also publishes invited minireviews and brief communications. The Editor-in-Chief invites timely articles to be published as minireviews. These minireviews are aimed at being short and focused on a contemporary topic. The invited minireviews consist of approximately 15 manuscript pages (approximately 350 words per page) and 15 scientific references. Minireviews must contain one figure highlighting the theme of the article, complete with an explanatory figure legend. If appropriate, a color version of the figure can be published in the online publication, with a black-and-white figure in the print version. If the author chooses this option, the figure legend must be self-explanatory in the absence of color-coding. Manuscripts published as brief communications are, primarily, reports of noteworthy findings that do not require extensive introduction or discussion. They may include findings of special interest, some kinds of preliminary results, or descriptions of methods, techniques, or reanalysis of data. Brief communications are subject to peer review, but an attempt will be made to accelerate the process, thereby shortening the interval between submission and publication. Papers will be considered brief communications if the text, references, and a maximum of two tables or figures (or one of each) are limited to 10 manuscript pages. Authors may elect to include additional illustrations, but the limitation to 10 manuscript pages will remain. The chief criteria for the acceptance of submitted papers are the quality, originality, and clarity of the work reported.
Form
Manuscripts should be prepared using a 12-point font, double-spaced throughout (including tables, footnotes, references, and figure captions) in an 8.5 x 11-in format with 1-in. margins on all sides. Unusual typeface is acceptable only if it is clear and legible. For initial submission, all text files must be prepared and submitted in one of the following formats: Microsoft Word (.doc), WordPerfect (.wps), Rich Text Format (.rtf), or Portable Document Format (.pdf). Please note, however, that the accepted manuscript must be submitted in an editable format (Word and .rtf formats are preferred); PDF files are not suitable for production purposes. For more information, please also see the Author Gateway Web page for Brain, Behavior, and Immunity available through the journal home page at http://www.elsevier.com/locate/ybrbi.
Page 1 should contain the article title, the names and affiliations of all authors, and, at the bottom of the page, the name, mailing address, e-mail address, telephone number, and Fax number of the person to whom correspondence, proofs, and reprint requests should be sent.
Page 2 should contain an abstract of the article that is not to exceed 250 words. A list of up to 10 keywords or phrases suitable for indexing should be provided in the electronic submission process.
Headings. The organization of the paper should be clearly indicated by appropriate headings and subheadings. After an introductory statement of the background and problem to be investigated, most manuscripts would be arranged under the following main headings: Methods, Results, Discussion, and References.
Abbreviations. Do not use periods after abbreviations of measure (cm, s, kg, mA, etc.) in text or tables, except for "in." (inch). The American Chemical Society Style Guide should be used as a reference for proper abbreviations.
Statistical analyses. Analysis of variance tables should not be submitted, but important F ratios should be presented in the text. Letters used as statistical symbols should be typed in italics. Common statistical tests need not be referenced. The appropriate form for presentation of statistical information should include degrees of freedom and p value (e.g., F(3,17) = 4.16, p < .05; t(22) = 2.97, p < .01; r(2,15) = 0.58, p < .05).
Footnotes. Footnotes should be used only when absolutely necessary. They should be identified in the text by consecutive superscript Arabic numerals and typed double-spaced on a separate page.
References. The name and date system should be used for citing all references. All citations in the text should refer to:
1. Single author: the author's name (without initials, unless there is ambiguity) and the year of publication.
2. Two authors: both authors' names and the year of publication.
3. Three or more authors: first author's name followed by et al. and the year of publication.
Examples: "as demonstrated (Allan, 1996a, 1996b, 1999; Allan and Jones, 1995). Kramer et al. (2000) have recently shown"
References should be arranged first alphabetically and then further sorted chronologically if necessary. More than one reference from the same author(s) in the same year must be identified by the letters "a", 'b", "c", etc., placed after the year of publication.
For journal names follow the abbreviations in the most recent edition of the Chemical Abstracts Service Source Index.
Note the following examples:
Ader, R., Felten, D.L., Cohen, N. (Eds.), 2001. Psychoneuroimmunology, 3rd ed. Academic Press, New York.
Dwyer, J.M., 1993. Immunology: a historical perspective. In Sigal, L.H., Ron, Y. (Eds.), Immunology and Inflammation, McGraw Hill, New York, pp. 1-11.
French, R.A., Zachary, J.F., Dantzer, R., Frawley, L.S., Chizzonite, R., Parnet, P., Kelley, K.W., 1996. Dual expression of p80 type I and p68 type II interleukin-1 receptors on anterior pituitary cells synthesizing growth hormone. Endocrinology 137, 4027-4036.
Kiecolt-Glaser, J.K., 1999. Stress, personal relationships, and immune function: health implications. Brain, Behav. Immun. 13, 61-72.
Tables. Number tables consecutively with Arabic numerals in order of appearance in the text. Tables should be double-spaced on separate pages that follow the References. The title (centered above each table) and footnotes (typed beneath the table) should contain all the information necessary to understand and interpret the table without reference to the text. Footnotes to tables should be identified by superscript lowercase letters and assigned alphabetically in order of appearance as the table is read horizontally.
Graphs. Graphs and charts should be in a finished form suitable for high-quality journal reproduction. Units of measurement should be given in the ordinate and abscissa. Graphs and charts can be submitted as Powerpoint (.ppt), Tagged-Image File Format (.tiff or .tif), or Encapsulated PostScript (.eps) files. If graphs are submitted in color, they must be saved in the CMYK (Cyan, Magenta, Yellow, Black) mode for color. If a .tiff (.tif) format is being used and the file is greater than 10 MB, file size should be reduced by using LZW compression. Following preparation of graphs, scans, and illustrations (see below), all figures should be numbered consecutively with Arabic numerals in order of appearance in the text, including figures with more than one part (i.e., Fig. 1A, Fig. 1B, Fig. 1C). All images should then be inserted at the end of the manuscript (one illustration per page). The top of the figure should be clearly designated, and the name of the first author and abbreviated title of the manuscript should be at the top of each page that contains the image. If the manuscript is accepted for publication, each graph must be supplied as a separate file in a .ppt, .tif, or .eps format. For more specific instructions, view "Artwork instructions" on the author gateway available on the journal home page at http://www.elsevier.com/locate/ybrbi. The cost of print color reproduction will be charged to the author(s).
Scans and illustrations. Scans should be prepared using high-quality image editing software such as Adobe Photoshop or Corel Photo-Paint. Illustrations should be constructed with high-resolution software such as Adobe Illustrator or CorelDRAW. All images should be in a finished form suitable for publication. Scans and drawings may be either 87 mm (one column or one-half page) or 178 mm (two column or full page) wide. Both widths require resolutions yielding 600 dots per inch/pixels per inch (dpi/ppi) or greater. If scans or illustrations are to be printed in color, it is important that the images be saved in the CMYK mode for color. Scans and illustrations can be submitted either as .tiff (.tif) or .eps files. If a .tiff (.tif) format is being used and the file is greater than 10 MB, file size should be reduced by using LZW compression. All images should be numbered consecutively with Arabic numerals in order of appearance in the text, including figures with more than one part (i.e., Fig. 1A, Fig. 1B, Fig. 1C). The images should then be inserted at the end of the manuscript (one illustration per page). The top of the figure should be clearly designated, and the name of the first author and abbreviated title of the manuscript should be at the top of each page. If the manuscript is accepted for publication, each high-resolution scan or illustration must be supplied as an individual source file in either a .tiff or .eps format. For more specific instructions, view "Artwork instructions" on the author gateway available on the journal home page at http://www.elsevier.com/locate/ybrbi. The cost of print color reproduction will be charged to the author(s).
GenBank/DNA sequence linking. Brain, Behavior, and Immunity cites "gene accession numbers" in its running text and footnotes. Gene accession numbers refer to genes or DNA sequences about which further information can be found in the databases at the National Center for Biotechnical Information (NCBI) at the National Library of Medicine. Brain, Behavior, and Immunity authors wishing to enable other scientists to use the accession numbers cited in their papers via links to these sources should type this information in the following manner:
For each and every accession number cited in an article, authors should type the accession number in bold, underlined text. Letters in the accession number should always be capitalized (see Example 1 below). This combination of letters and format will enable Elsevier's typesetters to recognize the relevant texts as accession numbers and add the required link to GenBank's sequences.
Example 1: GenBank accession nos. AI631510, AI631511, AI632198, and BF223228), a B-cell tumor from a chronic lymphatic leukemia (GenBank accession no. BE675048), and a T-cell lymphoma (GenBank accession no. AA361117).
Authors are encouraged to check accession numbers used very carefully. An error in a letter or number can result in a dead link.
In the final version of the printed article, the accession number text will not appear bold or underlined (see Example 2 below).
Example 2: GenBank accession nos. AI631510, AI631511, AI632198, and BF223228), a B-cell tumor from a chronic lymphatic leukemia (GenBank accession no. BE675048), and a T-cell lymphoma (GenBank accession no. AA361117).
In the final version of the electronic copy, the accession number text will be linked to the appropriate source in the NCBI databases, enabling readers to go directly to that source from the article (see Example 3 below).
Example 3: GenBank accession nos. AI631510, AI631511, AI632198, and BF223228), a B-cell tumor from a chronic lymphatic leukemia (GenBank accession no. BE675048), and a T-cell lymphoma (GenBank accession no. AA361117).
Proofs
The manuscript will be edited according to the style of the journal, and authors must read the proofs carefully. Alterations in excess of 10% of the cost of composition will be charged to the author(s).
Announcements
Brain, Behavior, and Immunity will consider for publication announcements of interest to the readership such as notices of scientific meetings.
Editorial Board
|
Editor-in-Chief
|
|
K.W. Kelley, University of Illinois at Urbana-Champaign, Laboratory of Immunophysiology, Department of Animal Sciences, 212 Edward R. Madigan Laboratory, 1201 West Gregory Drive, Urbana, Illinois 61801
|
|
|
Associate Editors
|
|
R. Dantzer, INRA-Inserm U 394, Rue Camille Saint-Saëns, Institute Francois Magendie, 33077 Bordeaux Cedex, France
|
|
|
M. Irwin, Cousins Center for Psychoneuroimmunology, UCLA Neuropsychiatric Institute, Mail Code 707624, 300 Medical Plaza, Suite 3109, Los Angeles, California 90095-7076
|
|
|
V.M. Sanders, Department of Molecular Virology, Immunology & Medical Genetics, The Ohio State University, 2194 Graves Hall, 333 W. 10th Avenue, Columbus, Ohio 43210
|
|
|
Editorial Board
|
|
R. Ader, University of Rochester Medical Center, Rochester, New York
|
|
|
M. Antoni, University of Miami, Coral Gables, Florida
|
|
|
W.A. Banks, St. Louis University and Veterans Affairs Medical Center, St. Louis, Missouri
|
|
|
D. Bellinger, Loma Linda University School of Medicine, Loma Linda, California
|
|
S. Ben-Eliyahu, Tel Aviv University, Tel Aviv, Israel
|
|
C. Coe, University of Wisconsin, Madison, Wisconsin
|
|
S. Cohen, Carnegie-Mellon University, Pittsburgh, Pennsylvania
|
|
N. Cohen, University of Rochester Medical Center, Rochester, New York
|
|
A.J. Dunn, Louisiana State University School of Medicine, Shreveport, Louisiana
|
|
T.K. Eisenstein, Temple University School of Medicine, Philadelphia, Pennsylvania
|
|
R. Glaser, The Ohio State University, Columbus, Ohio
|
|
R.M. Gorczynski, University of Toronto, Toronto, Ontario, Canada
|
|
C.J. Heijnen, Het Wilhelmina Kinderziekenhuis, Utrecht, The Netherlands
|
|
D.S. Jessop, University of Bristol, Bristol, United Kingdom
|
|
R.W. Johnson, University of Illinois, Urbana, Illinois
|
|
J.K. Kiecolt-Glaser, The Ohio State University College of Medicine, Columbus, Ohio
|
D.T. Lysle, Univesity of North Carolina at Chapel Hill, Chapel Hill, North Carolina
|
|
S.F. Maier, University of Colorado, Boulder, Colorado
|
|
B.S. McEwen, The Rockefeller University, New York, New York
|
|
A. Miller, Emory University School of Medicine, Atlanta, Georgia
|
|
J.A. Moynihan, University of Rochester Medical Center, Rochester, New York | |
|
N. Rothwell, University of Manchester, Manchester, England
|
|
M. Schedlowski, Essen University, Essen, Germany
|
|
S.J. Schleifer, New Jersey Medical School, Newark, New Jersey
|
|
B. Sharp, University of Tennessee College of Medicine, Memphis, Tennessee
|
|
J.F. Sheridan, The Ohio State University, Columbus, Ohio
|
|
E.M. Smith, University of Texas Medical Branch, Galveston, Galveston, Texas
| Dr. Keith W. Kelley
Editor-in-Chief, Brain, Behavior, and Immunity
University of Illinois at Urbana-Champaign
Laboratory of Immunophysiology
Department of Animal Sciences
212 Edward R. Madigan Laboratory
1201 West Gregory Drive
Urbana, IL 61801, USA
bbieditor@uiuc.edu
Telephone: (217) 333-9641
Fax: (217) 244-5617
|
刊名字顺( Alphabetical List of Journals):
返回页首 